Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China New Enterprise Invests Additional $25 Million in Shanghai Fudan-Zhangjiang

publication date: Nov 7, 2013
China New Enterprise Investment, a growth capital firm, will invest $25.4 million to buy additional shares in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical. CNEI is said to have invested $20 million SFZJ earlier this year and owned 14% of the company’s Hong Kong-listed and domestic shares before the latest investment. SFZJ is an innovative drug company that listed on the Hong Kong Growth Enterprise Market in 2002.  More details....

Stock Symbol: (HK: 8231)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital